Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Moleculin Announces Additional Positive Interim Results in Studies of Annamycin in AML in Europe

americanpharmaceuticalreviewMay 08, 2019

Tag: Moleculin , AML , Annamycin

PharmaSources Customer Service